JNCI Cancer Spectrum

SJR Rank #1,912H-index: 46SJR: 1.720Best quartile: Q1Open AccessAPC: US$2,050Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Oxford University Press

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • OncologyQ1
  • Cancer ResearchQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Global Cancer Incidence and ScreeningCancer survivorship and careCancer Risks and FactorsEconomic and Financial Impacts of CancerChildhood Cancer Survivors' Quality of LifeBRCA gene mutations in cancerColorectal Cancer Screening and DetectionBreast Cancer Treatment StudiesProstate Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs080160240320

Documents per Year

2022202503570105140

Detailed Information

ISSN

2515-5091

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.26

References per Document

38.23

Coverage

2017-2026

Scope

JNCI Cancer Spectrum is a peer-reviewed, open-access journal that publishes 6 issues per year online. The journal publishes manuscripts that describe new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research. In addition to novel results, the journal will also consider studies with meaningful confirmatory or negative findings, and it encourages systematic reviews, meta-analyses, and expert reviews of important topics. The journal also invites scholarly manuscripts discussing emerging hypotheses and research priorities. The journal employs a process of rigorous yet rapid review of submitted manuscripts so that findings of high scientific and medical interest can be published with minimum delay.

Metrics from SCImago Journal Rank 2025. View on SCImago